// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "RFC MS SWATH HANCESTRO AC CELL MHC TA PP CLO COULD organism part PMCID EBI exclamation PATO COLUMN QY CID alkylation reagent PRM AS CN SN HEREIN PEPTIDESEQ DOID NCBI WARRANTY MS:1001251 IAA INITIATIVE CPTAC individual MAJOR PO SRM EFO RECOMMEND REQUIRES SHOULD PRIDE OR THE cleavage agent details mass OPTIONAL ZFA SDRF PRIDE:0000659 ISA DJ PS SILAC DISCLAIMS PSI HTML MT ALL UBERON TO MAGE CV age TIP MERCHANTABILITY cell type BRENDA biosample accession number ENVO ... USE JA DTT data file CS IDF FOR technical replicate README EW MONDO PURPOSE fraction identifier BTO DIA SH URL disease stage TAB FITNESS DDA THAT dissociation method replicate BMC EXPRESS VK instrument disease biological replicate LIMITED source name_ and _assay name source name LC IMPORTANT TMT CF file your FDR SP INFORMATION INCLUDING HF ROW PMID MINOR fractionation method collision energy BUT NOT INFRINGE RECOMMENDED WARRANTIES RIGHTS spiked compound NCE reduction reagent developmental stage RAW REQUIRED IS organism proteomics data acquisition method PATCH URI HCD BE II MAY CT PTM PROTEOMICS ANY PARTICULAR EM MC label sample MIAME ancestry category SHALL ID STANDARDS MUST NOTE IMPLIED WILL depletion sex NT MANDATORY pooled sample characteristics CL MOD XL III XML OF LI HUPO"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "RFC MS SWATH HANCESTRO AC CELL MHC TA PP CLO COULD organism part PMCID EBI PATO COLUMN QY CID alkylation reagent PRM AS CN SN HEREIN PEPTIDESEQ DOID NCBI WARRANTY MS:1001251 IAA INITIATIVE CPTAC individual MAJOR PO SRM EFO RECOMMEND REQUIRES SHOULD PRIDE OR THE cleavage agent details mass OPTIONAL ZFA SDRF PRIDE:0000659 ISA DJ PS SILAC DISCLAIMS PSI HTML MT ALL UBERON TO MAGE CV age MERCHANTABILITY cell type BRENDA biosample accession number ENVO ... USE JA DTT data file CS IDF FOR technical replicate README EW MONDO PURPOSE fraction identifier BTO DIA SH URL disease stage TAB FITNESS DDA THAT dissociation method BMC EXPRESS VK instrument disease biological replicate LIMITED LC TMT CF FDR SP INFORMATION INCLUDING HF ROW PMID MINOR fractionation method collision energy BUT NOT INFRINGE RECOMMENDED WARRANTIES RIGHTS spiked compound NCE reduction reagent developmental stage RAW REQUIRED IS organism proteomics data acquisition method PATCH URI HCD BE II MAY CT PTM PROTEOMICS ANY PARTICULAR EM MC label MIAME ancestry category SHALL STANDARDS MUST IMPLIED WILL depletion sex NT MANDATORY pooled sample CL MOD XL III OF LI HUPO"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "UBERON:0002107 HANCESTRO UBERON:0000948 organism part MONDO:0005148 PATO:0000383 PATO exclamation CL:0000066 CL:0000813 MONDO:0004975 enrichment process DSS MONDO:0005105 UBERON:0002097 DOID NCBI CL:0000624 PATO:0000461 individual PO CL:0000540 CML EFO CL:0000235 SHOULD CSF SDRF APP MONDO:0008383 UBERON:0000955 synthetic peptide ALL UBERON CL:0000236 UBERON:0001977 age TIP cell type MONDO:0005138 CL:0000576 UBERON:0001155 CL:0000913 UBERON:0002048 NK CL:0000233 CL:0000815 MONDO URL MONDO:0005575 PATO:0001340 CL:0000232 CL:0000057 CL:0000787 disease biological replicate MONDO:0004946 COVID MONDO:0004989 MONDO:0100096 source name IMPORTANT UBERON:0000178 UBERON:0001088 lib MONDO:0005180 CL:0000451 CL:0000788 compound PDX developmental stage organism CL:0000182 MAY PTM UBERON:0000310 ancestry category ID MUST CL:0000898 UBERON:0002113 MONDO:0005301 NOTE CL:0000084 CL:0000625 UBERON:0001359 depletion sex UBERON:0001969 CL:0000623 NSG CL xenograft disease model PATO:0000384"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "UBERON:0002107 HANCESTRO UBERON:0000948 organism part MONDO:0005148 PATO:0000383 PATO CL:0000066 CL:0000813 MONDO:0004975 enrichment process DSS MONDO:0005105 UBERON:0002097 DOID NCBI CL:0000624 PATO:0000461 individual PO CL:0000540 CML EFO CL:0000235 SHOULD CSF SDRF APP MONDO:0008383 UBERON:0000955 synthetic peptide ALL UBERON CL:0000236 UBERON:0001977 age cell type MONDO:0005138 CL:0000576 UBERON:0001155 CL:0000913 UBERON:0002048 NK CL:0000233 CL:0000815 MONDO URL MONDO:0005575 PATO:0001340 CL:0000232 CL:0000057 CL:0000787 disease biological replicate MONDO:0004946 COVID MONDO:0004989 MONDO:0100096 source name UBERON:0000178 UBERON:0001088 MONDO:0005180 CL:0000451 CL:0000788 compound PDX developmental stage organism CL:0000182 MAY PTM UBERON:0000310 ancestry category ID MUST CL:0000898 UBERON:0002113 MONDO:0005301 CL:0000084 CL:0000625 UBERON:0001359 depletion sex UBERON:0001969 CL:0000623 NSG CL xenograft disease model PATO:0000384"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C65107 HANCESTRO NCIT:C53556 PREFERRED PD NCIT:C81327 NCIT:C14167 organism part MONDO:0005148 pre-existing condition NCIT:C62723 exclamation secondary condition NCI NCIT:C18206 NCIT:C27966 pregnancy status NCIT:C65108 NCIT:C15445 height treatment status NCIT:C28054 HANCESTRO:0010 UO ER NCIT:C15632 NCIT:C28079 individual NCIT:C14169 IV NCIT:C14174 NCIT:C18213 dose EFO sampling time point NCIT:C15329 NCIT:C27970 SDRF TNM staging NCIT diet weight NCIT:C28078 MONDO:0004995 age TNM menopausal status body mass index NCIT:C18058 HIPAA alcohol consumption NCIT:C14168 NCIT:C4870 MONDO NCIT:C65106 MONDO:0011122 disease stage HANCESTRO:0009 smoking status prior treatment disease HANCESTRO:0005 GDPR NCIT:C15262 NCIT:C53555 gestational age NCIT:C28077 PR IMPORTANT time post treatment CHEBI:41774 Ann Arbor stage NCIT:C68804 treatment response NCIT:C53553 MONDO:0005300 CHEBI:6801 NCIT:C16358 compound tumor grade ACE MONDO:0005044 organism BMI II NCIT:C71732 NCIT:C28076 AJCC ancestry category MONDO:0002050 NCIT:C27971 ID NOTE CHEBI:28748 Dukes stage sex MONDO:0004979 CHEBI:27899 NCIT:C81328 NCIT:C15313 HANCESTRO:0006 medication history III ethnicity NCIT:C53554 treatment breast cancer subtype"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C65107 HANCESTRO NCIT:C53556 PREFERRED PD NCIT:C81327 NCIT:C14167 organism part MONDO:0005148 pre-existing condition NCIT:C62723 secondary condition NCI NCIT:C18206 NCIT:C27966 pregnancy status NCIT:C65108 NCIT:C15445 height treatment status NCIT:C28054 HANCESTRO:0010 UO ER NCIT:C15632 NCIT:C28079 individual NCIT:C14169 IV NCIT:C14174 NCIT:C18213 dose EFO sampling time point NCIT:C15329 NCIT:C27970 SDRF TNM staging NCIT diet weight NCIT:C28078 MONDO:0004995 age TNM menopausal status body mass index NCIT:C18058 HIPAA alcohol consumption NCIT:C14168 NCIT:C4870 MONDO NCIT:C65106 MONDO:0011122 disease stage HANCESTRO:0009 smoking status prior treatment disease HANCESTRO:0005 GDPR NCIT:C15262 NCIT:C53555 gestational age NCIT:C28077 PR time post treatment CHEBI:41774 Ann Arbor stage NCIT:C68804 treatment response NCIT:C53553 MONDO:0005300 CHEBI:6801 NCIT:C16358 compound tumor grade ACE MONDO:0005044 organism BMI II NCIT:C71732 NCIT:C28076 AJCC ancestry category MONDO:0002050 NCIT:C27971 ID CHEBI:28748 Dukes stage sex MONDO:0004979 CHEBI:27899 NCIT:C81328 NCIT:C15313 HANCESTRO:0006 medication history III ethnicity NCIT:C53554 treatment breast cancer subtype"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "SHOULD UNIMOD MS DIA fraction identifier PRIDE URL proteomics data acquisition method URI AC cleavage agent details DDA SDRF MRM LTQ TA TS PP scan window lower limit proteomexchange accession number fraction sample label MS:1001917 file uri instrument FTP UNIMOD:737 SILAC exclamation ID modification parameters MUST precursor mass tolerance PSI MT IMPORTANT NOTE TMT PRM UNIMOD:21 MGF PRIDE:0000663 scan window upper limit TIP CF RPPA MS:1001306 ELISA NT MS:1001303 SCIEX MS:1001251 MSD MS:1001309 HF MS:1001313 ST KR data file MM MOD XL CS UNIMOD:35 UNIMOD:4 fragment mass tolerance RECOMMENDED TOF technical replicate MS2 analyzer type SRM MS1 scan range RAW UNIMOD:1 REQUIRED"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "SHOULD UNIMOD MS DIA fraction identifier PRIDE URL proteomics data acquisition method URI AC cleavage agent details DDA SDRF MRM LTQ TA TS PP scan window lower limit proteomexchange accession number label MS:1001917 file uri instrument FTP UNIMOD:737 SILAC ID modification parameters MUST precursor mass tolerance PSI MT TMT PRM UNIMOD:21 MGF PRIDE:0000663 scan window upper limit CF RPPA MS:1001306 ELISA NT MS:1001303 SCIEX MS:1001251 MSD MS:1001309 HF MS:1001313 ST KR data file MM MOD XL CS UNIMOD:35 UNIMOD:4 fragment mass tolerance RECOMMENDED TOF technical replicate MS2 analyzer type SRM MS1 scan range RAW UNIMOD:1 REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Immunopeptidomics Template",
    "content": "SDRF-Proteomics: Immunopeptidomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating immunopeptidomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with immunopeptidomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nImmunopeptidomics is a specialized field of proteomics that focuses on the identification and characterization of peptides presented by major histocompatibility complex (MHC) molecules on the cell surface. These MHC-bound peptides, collectively known as the immunopeptidome, play a critical role in immune recognition and are essential for understanding:\n\n- T-cell mediated immune responses\n- Antigen presentation mechanisms\n- Tumor-associated antigens for cancer immunotherapy\n- Vaccine development and infectious disease research\n\nThis template defines the additional metadata requirements for properly annotating immunopeptidomics datasets in SDRF-Proteomics format, enabling better data sharing, reproducibility, and integration with immunological databases.\n\nMotivation\n\nImmunopeptidomics experiments have unique characteristics that distinguish them from standard proteomics workflows:\n\n1. Specialized sample preparation: MHC-peptide complexes require specific enrichment methods (e.g., immunoaffinity purification using anti-MHC antibodies)\n2. Short peptide focus: Unlike tryptic digests, immunopeptides are naturally processed and typically 8-15 amino acids for MHC class I or 13-25 amino acids for MHC class II\n3. HLA polymorphism: Human samples require HLA typing information to interpret peptide binding motifs\n4. No enzymatic digestion: Peptides are naturally cleaved by the immunoproteasome and other cellular proteases\n\nThese unique aspects require additional metadata beyond the standard SDRF-Proteomics fields to enable proper ",
    "url": "./templates/immunopeptidomics.html",
    "section": "Immunopeptidomics Template",
    "keywords": "organism cells fraction identifier PRIDE IMGT NGS MHC class cleavage agent details immunopeptidome enrichment method II SDRF MHC AW elution conditions cell line label immunopeptidome HLA antibody used instrument disease biological replicate exclamation MHC binding prediction HLA typing HLA typing method HTML SSO CV JY file your IEDB MRO tissue mass biosample accession number HF data file VO NOT individual cell number DR PCR RECOMMENDED TFA EFO REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Immunopeptidomics Template",
    "content": "SDRF-Proteomics: Immunopeptidomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating immunopeptidomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with immunopeptidomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nImmunopeptidomics is a specialized field of proteomics that focuses on the identification and characterization of peptides presented by major histocompatibility complex (MHC) molecules on the cell surface. These MHC-bound peptides, collectively known as the immunopeptidome, play a critical role in immune recognition and are essential for understanding:\n\n- T-cell mediated immune responses\n- Antigen presentation mechanisms\n- Tumor-associated antigens for cancer immunotherapy\n- Vaccine development and infectious disease research\n\nThis template defines the additional metadata requirements for properly annotating immunopeptidomics datasets in SDRF-Proteomics format, enabling better data sharing, reproducibility, and integration with immunological databases.\n\nMotivation\n\nImmunopeptidomics experiments have unique characteristics that distinguish them from standard proteomics workflows:\n\n1. Specialized sample preparation: MHC-peptide complexes require specific enrichment methods (e.g., immunoaffinity purification using anti-MHC antibodies)\n2. Short peptide focus: Unlike tryptic digests, immunopeptides are naturally processed and typically 8-15 amino acids for MHC class I or 13-25 amino acids for MHC class II\n3. HLA polymorphism: Human samples require HLA typing information to interpret peptide binding motifs\n4. No enzymatic digestion: Peptides are naturally cleaved by the immunoproteasome and other cellular proteases\n\nThese unique aspects require additional metadata beyond the standard SDRF-Proteomics fields to enable proper ",
    "url": "./templates/immunopeptidomics.html#sdrf-proteomics-immunopeptidomics-template",
    "section": "Immunopeptidomics Template",
    "keywords": "organism fraction identifier PRIDE IMGT NGS MHC class cleavage agent details immunopeptidome enrichment method II SDRF MHC AW elution conditions cell line label HLA antibody used instrument disease biological replicate MHC binding prediction HLA typing HLA typing method HTML SSO CV JY IEDB MRO tissue mass biosample accession number HF data file VO NOT individual cell number DR PCR RECOMMENDED TFA EFO REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Affinity Proteomics Template",
    "content": "SDRF-Proteomics: Affinity Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating affinity-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with affinity proteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nAffinity proteomics encompasses experimental approaches that use affinity-based capture methods to study specific protein subsets or interactions. Unlike mass spectrometry-based proteomics, these methods typically use antibodies, aptamers, or other affinity reagents to detect and quantify proteins. Major platforms include:\n\n- Proximity Extension Assay (PEA): Olink platform using antibody pairs and DNA barcoding\n- Aptamer-based assays: SomaScan platform using modified aptamers (SOMAmer reagents)\n- Antibody arrays: Various bead-based and planar array platforms\n- Immunoaffinity-MS: Hybrid approaches combining affinity capture with MS detection\n\nThis template defines metadata requirements for annotating these diverse affinity-based proteomics experiments, enabling data integration across platforms and with mass spectrometry data.\n\nMotivation\n\nAffinity proteomics experiments have characteristics that differ significantly from mass spectrometry proteomics:\n\n1. Pre-defined protein panels: Target proteins are determined by the reagent panel, not by detection\n2. No mass spectrometry (typically): Detection is often via sequencing, fluorescence, or electrochemiluminescence\n3. High throughput: Many samples can be processed in parallel\n4. Different quantification scales: Relative units (NPX, RFU) rather than intensity or spectral counts\n5. Platform-specific considerations: Each technology has unique metadata requirements\n\nThese aspects require specific metadata to enable proper data interpretation and cross-platform co",
    "url": "./templates/affinity-proteomics.html",
    "section": "Affinity Proteomics Template",
    "keywords": "organism MS standard curve CSF detection sensitivity NPX normalization assay platform antibody source QC normalization method dilution factor SDRF II MRM olink platform detection method capture antibody IP disease panel composition exclamation sample type MUST PEA ELLA CSV SISCAPA enrichment method HTML somascan platform target protein class IMPORTANT NOTE GFP JM panel version QC warning CV FLAG EDTA affinity reagent olink lot number sample volume file your RPPA bead type HT RFU MULTI quantification unit ARRAY NPX panel name biosample accession number MSD somascan menu sample matrix data file olink panel HA LOD MFI RECOMMENDED DNA ADAT affinity method ONE NHS REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Affinity Proteomics Template",
    "content": "SDRF-Proteomics: Affinity Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating affinity-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with affinity proteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nAffinity proteomics encompasses experimental approaches that use affinity-based capture methods to study specific protein subsets or interactions. Unlike mass spectrometry-based proteomics, these methods typically use antibodies, aptamers, or other affinity reagents to detect and quantify proteins. Major platforms include:\n\n- Proximity Extension Assay (PEA): Olink platform using antibody pairs and DNA barcoding\n- Aptamer-based assays: SomaScan platform using modified aptamers (SOMAmer reagents)\n- Antibody arrays: Various bead-based and planar array platforms\n- Immunoaffinity-MS: Hybrid approaches combining affinity capture with MS detection\n\nThis template defines metadata requirements for annotating these diverse affinity-based proteomics experiments, enabling data integration across platforms and with mass spectrometry data.\n\nMotivation\n\nAffinity proteomics experiments have characteristics that differ significantly from mass spectrometry proteomics:\n\n1. Pre-defined protein panels: Target proteins are determined by the reagent panel, not by detection\n2. No mass spectrometry (typically): Detection is often via sequencing, fluorescence, or electrochemiluminescence\n3. High throughput: Many samples can be processed in parallel\n4. Different quantification scales: Relative units (NPX, RFU) rather than intensity or spectral counts\n5. Platform-specific considerations: Each technology has unique metadata requirements\n\nThese aspects require specific metadata to enable proper data interpretation and cross-platform co",
    "url": "./templates/affinity-proteomics.html#sdrf-proteomics-affinity-proteomics-template",
    "section": "Affinity Proteomics Template",
    "keywords": "organism MS standard curve CSF detection sensitivity NPX normalization assay platform QC normalization method dilution factor SDRF II MRM olink platform detection method capture antibody IP disease panel composition sample type MUST PEA ELLA CSV SISCAPA enrichment method HTML somascan platform target protein class panel version antibody source GFP JM QC warning CV FLAG EDTA affinity reagent olink lot number sample volume RPPA bead type HT RFU MULTI quantification unit ARRAY NPX panel name biosample accession number MSD somascan menu sample matrix data file olink panel HA LOD MFI RECOMMENDED DNA ADAT affinity method ONE NHS REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Single Cell Proteomics Template",
    "content": "SDRF-Proteomics: Single Cell Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating single cell proteomics (SCP) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with single-cell-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSingle cell proteomics (SCP) aims to characterize the proteome at the level of individual cells, providing insights into cellular heterogeneity that are not accessible through bulk proteomics methods. SCP enables the study of:\n\n- Cell-to-cell variability within populations\n- Rare cell populations and their unique protein signatures\n- Cellular state transitions and differentiation trajectories\n- Protein expression dynamics at single-cell resolution\n\nThis template defines the additional metadata requirements for properly annotating single cell proteomics datasets in SDRF-Proteomics format, supporting data integration, reproducibility, and cross-study comparisons.\n\nMotivation\n\nSingle cell proteomics experiments have unique characteristics that distinguish them from bulk proteomics:\n\n1. Cell isolation methods: Individual cells must be isolated using techniques like FACS, micromanipulation, or microfluidic platforms\n2. Ultra-low sample input: Working with picogram to low nanogram amounts of protein requires specialized sample preparation\n3. Carrier proteome strategies: Many SCP methods use carrier channels or carrier proteome to boost signal\n4. Cell-level metadata: Each cell requires individual annotation including cell identifiers and potentially spatial coordinates\n5. High-throughput multiplexing: Methods like SCoPE-MS and similar use TMT labeling to multiplex many cells per run\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nSingle cell pro",
    "url": "./templates/single-cell.html",
    "section": "Single Cell Template",
    "keywords": "organism fraction identifier MS PRIDE AC cells per well cleavage agent details carrier proteome SDRF label RNA RT instrument disease biological replicate cell identifier SCP LCM cell viability cell diameter exclamation cell collection method cell MUST missing value percentage HTML NOTE GFP TMT MS2 identification rate CV sorting marker spatial coordinates file your cell cycle phase cell type NT single cell isolation method section FACS MS:1001251 CL data file PI peptides identified EDAM carrier channel run ATAC well RECOMMENDED reference channel proteins identified EFO REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Single Cell Proteomics Template",
    "content": "SDRF-Proteomics: Single Cell Proteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating single cell proteomics (SCP) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with single-cell-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSingle cell proteomics (SCP) aims to characterize the proteome at the level of individual cells, providing insights into cellular heterogeneity that are not accessible through bulk proteomics methods. SCP enables the study of:\n\n- Cell-to-cell variability within populations\n- Rare cell populations and their unique protein signatures\n- Cellular state transitions and differentiation trajectories\n- Protein expression dynamics at single-cell resolution\n\nThis template defines the additional metadata requirements for properly annotating single cell proteomics datasets in SDRF-Proteomics format, supporting data integration, reproducibility, and cross-study comparisons.\n\nMotivation\n\nSingle cell proteomics experiments have unique characteristics that distinguish them from bulk proteomics:\n\n1. Cell isolation methods: Individual cells must be isolated using techniques like FACS, micromanipulation, or microfluidic platforms\n2. Ultra-low sample input: Working with picogram to low nanogram amounts of protein requires specialized sample preparation\n3. Carrier proteome strategies: Many SCP methods use carrier channels or carrier proteome to boost signal\n4. Cell-level metadata: Each cell requires individual annotation including cell identifiers and potentially spatial coordinates\n5. High-throughput multiplexing: Methods like SCoPE-MS and similar use TMT labeling to multiplex many cells per run\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nSingle cell pro",
    "url": "./templates/single-cell.html#sdrf-proteomics-single-cell-proteomics-template",
    "section": "Single Cell Template",
    "keywords": "organism fraction identifier MS PRIDE AC cells per well cleavage agent details carrier proteome SDRF label RNA RT instrument disease biological replicate cell identifier SCP LCM cell viability cell diameter cell collection method MUST missing value percentage HTML GFP TMT MS2 identification rate CV sorting marker spatial coordinates cell cycle phase cell type NT single cell isolation method FACS MS:1001251 CL data file PI peptides identified EDAM carrier channel ATAC RECOMMENDED reference channel proteins identified EFO REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template",
    "content": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating crosslinking mass spectrometry (XL-MS) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with crosslinking-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCrosslinking mass spectrometry (XL-MS) is a powerful structural proteomics technique that uses chemical reagents to covalently link amino acid residues in close spatial proximity. This approach provides valuable information for:\n\n- Protein structure determination and validation\n- Protein-protein interaction mapping\n- Characterization of protein complexes\n- Integrative structural biology pipelines\n- In vivo and in situ structural studies\n\nThis template defines the additional metadata requirements for properly annotating crosslinking mass spectrometry datasets in SDRF-Proteomics format, enabling proper interpretation of structural constraints and data reproducibility.\n\nMotivation\n\nCrosslinking mass spectrometry experiments have unique characteristics that distinguish them from standard proteomics:\n\n1. Crosslinking chemistry: Various reagents with different specificities and spacer arm lengths are used\n2. Distance constraints: The crosslinker spacer arm defines the maximum distance between linked residues\n3. Reaction conditions: Crosslinking efficiency depends on concentration, time, and temperature\n4. Specialized data analysis: XL-MS requires dedicated search engines that identify crosslinked peptide pairs\n5. Enrichment strategies: Crosslinked peptides are often enriched using specific strategies (SEC, SCX, affinity)\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Structural Biology\n\nCrosslinking mass spectrometry data is typically integrate",
    "url": "./templates/crosslinking.html",
    "section": "Crosslinking Template",
    "keywords": "organism crosslinks identified fraction identifier MS SA crosslinking reaction time SEC AC HCD cleavage agent details FAIMS DSBU SDRF EDC crosslink FDR crosslink search engine crosslinking context EM crosslinker concentration cell permeability label crosslink enrichment method instrument disease biological replicate exclamation quenching reagent PDB CID PSI HTML TG XLMOD:02001 SDA DSS crosslinking reagent CV crosslink distance fragmentation method for cleavage RP crosslink target residues crosslinking temperature file your FDR HADDOCK NT cell type prep cleavable crosslinker MS:1001251 xl crosslinking target IMP MS:1002494 data file XL XLMOD crosslinker spacer arm length SCX DSSO RECOMMENDED ETD FJ PIR crosslinker to protein ratio crosslink type NHS REQUIRED cleavage reporter ions"
  },
  {
    "title": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template",
    "content": "SDRF-Proteomics: Crosslinking Mass Spectrometry Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating crosslinking mass spectrometry (XL-MS) experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with crosslinking-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCrosslinking mass spectrometry (XL-MS) is a powerful structural proteomics technique that uses chemical reagents to covalently link amino acid residues in close spatial proximity. This approach provides valuable information for:\n\n- Protein structure determination and validation\n- Protein-protein interaction mapping\n- Characterization of protein complexes\n- Integrative structural biology pipelines\n- In vivo and in situ structural studies\n\nThis template defines the additional metadata requirements for properly annotating crosslinking mass spectrometry datasets in SDRF-Proteomics format, enabling proper interpretation of structural constraints and data reproducibility.\n\nMotivation\n\nCrosslinking mass spectrometry experiments have unique characteristics that distinguish them from standard proteomics:\n\n1. Crosslinking chemistry: Various reagents with different specificities and spacer arm lengths are used\n2. Distance constraints: The crosslinker spacer arm defines the maximum distance between linked residues\n3. Reaction conditions: Crosslinking efficiency depends on concentration, time, and temperature\n4. Specialized data analysis: XL-MS requires dedicated search engines that identify crosslinked peptide pairs\n5. Enrichment strategies: Crosslinked peptides are often enriched using specific strategies (SEC, SCX, affinity)\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Structural Biology\n\nCrosslinking mass spectrometry data is typically integrate",
    "url": "./templates/crosslinking.html#sdrf-proteomics-crosslinking-mass-spectrometry-template",
    "section": "Crosslinking Template",
    "keywords": "organism crosslinks identified fraction identifier MS SA crosslinking reaction time SEC AC HCD cleavage agent details FAIMS DSBU SDRF EDC crosslink FDR crosslink search engine crosslinking context EM crosslinker concentration cell permeability label crosslink enrichment method instrument disease biological replicate quenching reagent PDB CID PSI HTML TG XLMOD:02001 SDA DSS crosslinking reagent CV crosslink distance fragmentation method for cleavage RP crosslink target residues crosslinking temperature FDR HADDOCK NT cell type cleavable crosslinker MS:1001251 crosslinking target IMP MS:1002494 data file XL XLMOD crosslinker spacer arm length SCX DSSO RECOMMENDED ETD FJ PIR crosslinker to protein ratio crosslink type NHS REQUIRED cleavage reporter ions"
  },
  {
    "title": "SDRF-Proteomics: Metaproteomics Template",
    "content": "SDRF-Proteomics: Metaproteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating metaproteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with metaproteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nMetaproteomics is the study of proteins expressed by microbial communities, providing insights into the functional potential and activity of microbiomes. Unlike single-organism proteomics, metaproteomics analyzes complex samples containing proteins from many different organisms simultaneously. Key applications include:\n\n- Gut microbiome functional characterization\n- Environmental microbiology (soil, ocean, wastewater)\n- Host-microbiome interactions\n- Pathogen-host dynamics\n- Industrial biotechnology (bioreactors, fermentation)\n\nThis template defines the additional metadata requirements for properly annotating metaproteomics datasets in SDRF-Proteomics format, addressing the unique challenges of multi-organism samples.\n\nMotivation\n\nMetaproteomics experiments have unique characteristics that distinguish them from single-organism proteomics:\n\n1. Multi-organism samples: Samples contain proteins from many different species/taxa\n2. Complex sample matrices: Environmental, fecal, or other challenging sample types\n3. Database construction challenges: Sequence databases may be constructed from metagenomics data\n4. Taxonomic attribution: Peptides may be assigned to specific taxa or remain ambiguous\n5. Environmental context: Geographic, temporal, and environmental conditions are critical metadata\n6. Host-microbe separation: For host-associated microbiomes, host proteins may need to be distinguished\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nMetaproteomics data is ",
    "url": "./templates/metaproteomics.html",
    "section": "Metaproteomics Template",
    "keywords": "organism PL fraction identifier salinity ISO AC cleavage agent details mock community composition temperature sample collection method SDRF land use depth environmental sample type host disease host age water body type label ITS GAZ:00002459 USA GTDB body site biological replicate instrument exclamation altitude GAZ microbiome source UHGG REQUIRED soil type soil horizon sample storage HTML NOTE expected organism list CV chlorophyll pH host contamination host diet database search strategy vegetation file your host organism metagenome accession MSA NT collection date PSU NCBI MS:1001251 biomass estimation HF ENVO data file geographic location ATCC mock community contaminant database RECOMMENDED sed farm dissolved oxygen sampling depth zone antibiotic treatment EFO MONDO"
  },
  {
    "title": "SDRF-Proteomics: Metaproteomics Template",
    "content": "SDRF-Proteomics: Metaproteomics Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating metaproteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with metaproteomics-specific metadata fields.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nMetaproteomics is the study of proteins expressed by microbial communities, providing insights into the functional potential and activity of microbiomes. Unlike single-organism proteomics, metaproteomics analyzes complex samples containing proteins from many different organisms simultaneously. Key applications include:\n\n- Gut microbiome functional characterization\n- Environmental microbiology (soil, ocean, wastewater)\n- Host-microbiome interactions\n- Pathogen-host dynamics\n- Industrial biotechnology (bioreactors, fermentation)\n\nThis template defines the additional metadata requirements for properly annotating metaproteomics datasets in SDRF-Proteomics format, addressing the unique challenges of multi-organism samples.\n\nMotivation\n\nMetaproteomics experiments have unique characteristics that distinguish them from single-organism proteomics:\n\n1. Multi-organism samples: Samples contain proteins from many different species/taxa\n2. Complex sample matrices: Environmental, fecal, or other challenging sample types\n3. Database construction challenges: Sequence databases may be constructed from metagenomics data\n4. Taxonomic attribution: Peptides may be assigned to specific taxa or remain ambiguous\n5. Environmental context: Geographic, temporal, and environmental conditions are critical metadata\n6. Host-microbe separation: For host-associated microbiomes, host proteins may need to be distinguished\n\nThese aspects require additional metadata beyond standard SDRF-Proteomics fields.\n\nConnections to Other Omics Fields\n\nMetaproteomics data is ",
    "url": "./templates/metaproteomics.html#sdrf-proteomics-metaproteomics-template",
    "section": "Metaproteomics Template",
    "keywords": "organism PL fraction identifier salinity ISO AC cleavage agent details mock community composition temperature sample collection method SDRF land use depth environmental sample type host disease host age water body type label ITS GAZ:00002459 USA GTDB body site biological replicate instrument altitude GAZ microbiome source UHGG REQUIRED soil type soil horizon sample storage HTML expected organism list CV chlorophyll pH host contamination host diet database search strategy vegetation host organism metagenome accession MSA NT collection date PSU NCBI MS:1001251 biomass estimation HF ENVO data file geographic location ATCC mock community contaminant database RECOMMENDED dissolved oxygen sampling depth zone antibiotic treatment EFO MONDO"
  },
  {
    "title": "SDRF-Proteomics: Cell Line Template",
    "content": "SDRF-Proteomics: Cell Line Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating cell line-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with cell line-specific metadata fields and resources.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCell lines are extensively used in proteomics research, both for biological studies and for technology/method development. Cell lines present unique annotation challenges because:\n\n- They have well-defined characteristics that can be retrieved from databases\n- Metadata like sex, age, and disease refer to the original donor, not the cell line passage\n- Multiple databases and ontologies exist for cell line identification\n- Cell lines may be misidentified, contaminated, or have undergone genetic drift\n\nThis template defines standardized approaches for annotating cell line experiments, including the use of Cellosaurus as the primary resource for cell line identification and metadata.\n\nMotivation\n\nCell line annotation in proteomics datasets has historically been inconsistent:\n\n1. Multiple naming conventions: HeLa, HELA, He-La may all refer to the same cell line\n2. Outdated ontologies: The Cell Line Ontology (CLO) has not been actively maintained\n3. Missing metadata: Key information about donor characteristics is often omitted\n4. No standard identifiers: Lack of consistent accession numbers for cell lines\n\nThis template addresses these issues by:\n\n- Recommending Cellosaurus as the primary cell line resource\n- Providing a curated database of cell line metadata for SDRF annotation\n- Defining which metadata fields should be populated from databases vs. experiment-specific annotation\n\nCellosaurus: The Primary Cell Line Resource\n\nCellosaurus is a comprehensive knowledge resource on cell lines maintained by the SIB Swiss I",
    "url": "./templates/cell-lines.html",
    "section": "Cell Lines Template",
    "keywords": "organism SHOULD BTO authentication method DSMZ DMEM bto cell line cell line synonyms cell line source ctrl EFO:0001185 SDRF CLO:0003684 SNP CLO BTO:0000567 organism part cell line cellosaurus name sampling site cell line modifications ancestry category mycoplasma status disease biological replicate exclamation cellosaurus accession ID FBS passage number HELA culture conditions HTML IMPORTANT GFP age MB file your STR sex cell type OS BRENDA RECOMMEND MDA RECOMMENDS treat CRISPR data file NOT SIB compound ATCC RECOMMENDED cell line notes ICLAC XXXX ECACC material type treatment developmental stage EFO RPMI REQUIRED"
  },
  {
    "title": "SDRF-Proteomics: Cell Line Template",
    "content": "SDRF-Proteomics: Cell Line Template\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this Template\n\nThis document provides guidelines for annotating cell line-based proteomics experiments in SDRF-Proteomics format. This template extends the core SDRF-Proteomics specification with cell line-specific metadata fields and resources.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nCell lines are extensively used in proteomics research, both for biological studies and for technology/method development. Cell lines present unique annotation challenges because:\n\n- They have well-defined characteristics that can be retrieved from databases\n- Metadata like sex, age, and disease refer to the original donor, not the cell line passage\n- Multiple databases and ontologies exist for cell line identification\n- Cell lines may be misidentified, contaminated, or have undergone genetic drift\n\nThis template defines standardized approaches for annotating cell line experiments, including the use of Cellosaurus as the primary resource for cell line identification and metadata.\n\nMotivation\n\nCell line annotation in proteomics datasets has historically been inconsistent:\n\n1. Multiple naming conventions: HeLa, HELA, He-La may all refer to the same cell line\n2. Outdated ontologies: The Cell Line Ontology (CLO) has not been actively maintained\n3. Missing metadata: Key information about donor characteristics is often omitted\n4. No standard identifiers: Lack of consistent accession numbers for cell lines\n\nThis template addresses these issues by:\n\n- Recommending Cellosaurus as the primary cell line resource\n- Providing a curated database of cell line metadata for SDRF annotation\n- Defining which metadata fields should be populated from databases vs. experiment-specific annotation\n\nCellosaurus: The Primary Cell Line Resource\n\nCellosaurus is a comprehensive knowledge resource on cell lines maintained by the SIB Swiss I",
    "url": "./templates/cell-lines.html#sdrf-proteomics-cell-line-template",
    "section": "Cell Lines Template",
    "keywords": "organism SHOULD BTO authentication method DSMZ DMEM bto cell line cell line synonyms cell line source EFO:0001185 SDRF CLO:0003684 SNP CLO BTO:0000567 organism part cell line cellosaurus name sampling site cell line modifications ancestry category mycoplasma status disease biological replicate cellosaurus accession ID FBS passage number HELA culture conditions HTML GFP age MB STR sex cell type OS CVCLXXXX BRENDA RECOMMEND MDA RECOMMENDS CRISPR data file NOT SIB compound ATCC RECOMMENDED cell line notes ICLAC XXXX ECACC material type treatment developmental stage EFO RPMI REQUIRED"
  }
];
